Drugs News and Research

RSS

Researchers create prostate cancer drug delivery system

Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.

10 Jan 2012

Roundup: Iowa weighs mental health care changes; Ariz. clinic seeks to cut ER costs

Republican and Democratic legislators and Gov. Terry Branstad have said they want to reform Iowa's mental health system to reduce waiting lists and provide more equitable services. Currently, each of Iowa's counties performs or contracts for mental health services for indigent residents. Critics contend the 99-county system has led to pockets of inferior, inequitable service, particularly in rural areas.

10 Jan 2012

Researchers uncover exact function of LARGE enzyme linked with MD

Researchers at the University of Iowa have worked out the exact function of an enzyme that is critical for normal muscle structure and is involved in several muscular dystrophies. The findings, which were published Jan. 6 in the journal Science,, could be used to develop rapid, large-scale testing of potential muscular dystrophy therapies.

10 Jan 2012

USPTO issues patent to Lixte's lead compounds for treatment of neurological diseases

Lixte Biotechnology Holdings announces that the United States Patent and Trademark Office awarded a patent for the use of lead compounds from each of two different types of drugs, protein phosphatase inhibitors and histone deacetylase inhibitors, for the potential prevention and treatment of neurodegenerative diseases.

9 Jan 2012

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 12-week phase IIb clinical trial of IDX184, the Company's lead product candidate for the treatment of hepatitis C virus (HCV) infection.

9 Jan 2012

More on the PIP breast implant scare

Model Jasmine Lennard underwent an emergency operation to replace her breast implants after discovering they contained banned silicone. The 26-year-old admits that she became ‘hysterical’ after discovering her implants came from French firm PIP, which is at the centre of a global health scare for using industrial-grade materials deemed unfit for medical use. And she believes last week’s procedure could have ‘saved my life’.

9 Jan 2012

Novartis recalls four OTC drugs citing factory malfunction

Swiss pharmaceutical firm Novartis has announced that it is recalling four different products sold over the counter in the United States after receiving reports that there if malfunction at one of its plants.

9 Jan 2012

Novel class of nanoparticles hold promise as a potential vehicle for drug delivery

In the images of fruit flies, clusters of neurons are all lit up, forming a brightly glowing network of highways within the brain. It’s exactly what University at Buffalo researcher Shermali Gunawardena was hoping to see: It meant that ORMOSIL, a novel class of nanoparticles, had successfully penetrated the insects’ brains. And even after long-term exposure, the cells and the flies themselves remained unharmed.

9 Jan 2012

Idenix Pharmaceuticals makes progress with its HCV development pipeline

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the advancement of its hepatitis C virus development pipeline.

9 Jan 2012

Middle-aged adults with diabetes have time to learn how to control hypertension

A new study suggests that middle-aged adults recently diagnosed with diabetes and hypertension have time to try to learn how to control their high blood pressure without medications, but not too much time.

9 Jan 2012

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces that it has signed an agreement with miRagen Therapeutics, Inc., to assess the delivery potential of Silence's proprietary DBTC delivery system with miRagen's novel microRNA-based therapeutics.

9 Jan 2012

AICAR therapy may combat heat stroke

We've all seen the story in the news before. Whether it's the death of a physically fit high school athlete at football training camp in August, or of an elderly woman gardening in the middle of the day in July, heat stroke is a serious, life-threatening condition for which there is no treatment beyond submersion in ice water or the application of ice packs to cool the body to a normal temperature.

8 Jan 2012

NCH voluntarily recalls certain over-the-counter drugs in the U.S.

Novartis Consumer Health, Inc. (NCH) announced today that it is voluntarily recalling all lots of select bottle packaging configurations of Excedrin and NoDoz products with expiry dates of December 20, 2014 or earlier as well as Bufferin and Gas-X Prevention products with expiry dates of December 20, 2013 or earlier, in the United States.

8 Jan 2012

Americans cutting costs by skipping prescription drugs

A Consumer Reports survey revealed that more Americans are ignoring their doctor’s advice and skipping prescription drugs or medical procedures to save money in 2011 than a year earlier.

8 Jan 2012

Austin Recovery, Emmy Award-winning 'Intervention' program team up to save an addict's life

Austin Recovery, the largest and most affordable not-for-profit drug and alcohol treatment center in Texas, has once again teamed up with the Emmy Award-winning "Intervention" program to save an addict's life.

7 Jan 2012

AVMA warns against further restrictions on cephalosporin usage in food animals that are not backed by science

The American Veterinary Medical Association (AVMA) announced today that the FDA's order prohibiting certain uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science.

7 Jan 2012

Illegal drug use may be affecting health, death rates worldwide, Lancet report says

"About 200 million people around the world use illegal drugs every year, and that may be taking a toll on health and death rates in various countries, says a report released Thursday in the Lancet," the Los Angeles Times' "Booster Shots" blog reports.

7 Jan 2012

Street News Service/IPS examine challenges of fighting HIV/AIDS in a Senegalese prison

Street News Service/Inter Press Service examines how Senegal is addressing HIV/AIDS among prisoners in a Dakar maximum-security facility. "Prisons are high-risk environments for the transmission of the disease, due to the prevalence of hard drugs, violence and sexual relations," the news service writes and discusses how addressing such issues can present challenges in the majority-Muslim country.

7 Jan 2012

Researchers crack structure and function of malarial protein

A biology lab at Washington University has just cracked the structure and function of a protein that plays a key role in the life of a parasite that killed 655,000 people in 2010.

7 Jan 2012

PCI Biotech focuses on localised cancer therapy with minimum side effects

Side effects are currently the biggest problem with any cancer treatment. A Norwegian biotech company is drawing closer to the goal of creating a treatment which kills only cancer cells, leaving other cells unaffected.

7 Jan 2012

Drugs News and Research

Researchers create prostate cancer drug delivery system

Roundup: Iowa weighs mental health care changes; Ariz. clinic seeks to cut ER costs

Researchers uncover exact function of LARGE enzyme linked with MD

USPTO issues patent to Lixte's lead compounds for treatment of neurological diseases

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

More on the PIP breast implant scare

Novartis recalls four OTC drugs citing factory malfunction

Novel class of nanoparticles hold promise as a potential vehicle for drug delivery

Idenix Pharmaceuticals makes progress with its HCV development pipeline

Middle-aged adults with diabetes have time to learn how to control hypertension

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

AICAR therapy may combat heat stroke

NCH voluntarily recalls certain over-the-counter drugs in the U.S.

Americans cutting costs by skipping prescription drugs

Austin Recovery, Emmy Award-winning 'Intervention' program team up to save an addict's life

AVMA warns against further restrictions on cephalosporin usage in food animals that are not backed by science

Illegal drug use may be affecting health, death rates worldwide, Lancet report says

Street News Service/IPS examine challenges of fighting HIV/AIDS in a Senegalese prison

Researchers crack structure and function of malarial protein

PCI Biotech focuses on localised cancer therapy with minimum side effects

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News